title: Antidrug Antibodies in Patients Treated with Alirocumab.
authors.affiliation: Sterling Research Group, Cincinnati, OH eroth@sterlingresearch.org.
authors.forename: Eli M
authors.initials: EM
authors.lastname: Roth
authors.affiliation: Washington University School of Medicine, St. Louis, MO.
authors.forename: Anne C
authors.initials: AC
authors.lastname: Goldberg
authors.affiliation: University of Milan Multimedica IRCCS, Milan, Italy.
authors.forename: Alberico L
authors.initials: AL
authors.lastname: Catapano
authors.affiliation: Regeneron Pharmaceuticals, Tarrytown, NY.
authors.forename: Albert
authors.initials: A
authors.lastname: Torri
authors.affiliation: Regeneron Pharmaceuticals, Tarrytown, NY.
authors.forename: George D
authors.initials: GD
authors.lastname: Yancopoulos
authors.affiliation: Regeneron Pharmaceuticals, Tarrytown, NY.
authors.forename: Neil
authors.initials: N
authors.lastname: Stahl
authors.affiliation: Sanofi, Bridgewater, NJ.
authors.forename: Aurélie
authors.initials: A
authors.lastname: Brunet
authors.affiliation: Sanofi, Chilly Mazarin, France.
authors.forename: Guillaume
authors.initials: G
authors.lastname: Lecorps
authors.affiliation: University of Edinburgh, Edinburgh, United Kingdom.
authors.forename: Helen M
authors.initials: HM
authors.lastname: Colhoun
mesh_terms: D000906:Antibodies; D000911:Antibodies, Monoclonal; D000924:Anticholesteremic Agents; D006801:Humans
chemical_list: D000906:Antibodies; D000911:Antibodies, Monoclonal; D000924:Anticholesteremic Agents